Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Learn which index funds have the lowest fees for retirement and how expense ratios impact your long-term returns. This guide highlights cost-conscious picks and practical tips.
27,216 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Investors are turning to ASML to gauge the health of the global chip cycle. This article breaks down the factors like...
Get a fresh, investor-focused look at hamilton (hg) 2025 earnings. We'll break down revenue engines, margins, and wha...
Nike faces a pivotal few years as it shifts toward direct-to-consumer and digital growth. This deep dive outlines whe...
Ballard Power is at a pivotal moment as 2025 unfolds. This guide breaks down what to watch in the Q4 transcript, how ...
Cursor CEO warns that relying on AI to bootstrap software—often labeled vibe coding—could create fragile foundations ...
Insider trading patterns at Palantir raise questions about the stock's growth path as defense sector stocks attract c...
XRP-linked ETFs attracted $1.77 million in new money, lifting total XRP ETF assets to about $1.12 billion, even as th...
AI-driven signals suggest XRP could break out to $1.40-$1.55 in the next 15 days, depending on clearing a key resista...
New student loan rules take effect on July 1, redefining borrowing limits and repayment options for millions of borro...
Oracle is at a crossroads: AI-enabled cloud growth and savvy capital management could unlock significant upside. Here...
Hudbay's 2025 earnings outlook hinges on copper and zinc markets, mine costs, and capital decisions. This guide break...